Hemoglobin Dunn: alpha 6 (A4) aspartic acid replaced by asparagine

Area of Science:

• Biochemistry
• Genetics
• Hematology

Background:

• Hemoglobinopathies represent a group of inherited blood disorders.
• Hemoglobin variants arise from mutations in globin genes, potentially affecting protein structure and function.
• Identifying novel hemoglobin variants is crucial for understanding their clinical significance.

Purpose of the Study:

• To report the discovery and characterization of a new hemoglobin variant, Hemoglobin Dunn.
• To describe the genetic and structural properties of Hemoglobin Dunn.
• To evaluate the clinical and hematological impact of Hemoglobin Dunn.

Main Methods:

• High-performance liquid chromatography (HPLC) for initial detection.
• Mass spectrometry for structural elucidation.
• DNA sequencing for genetic analysis.

Main Results:

• Hemoglobin Dunn identified as an alpha 6 (A4) Aspartic acid to Asparagine substitution.
• The variant was found in a 39-year-old African American woman and her daughter.
• Hematological parameters and clinical examinations of the propositus were within normal limits.

Conclusions:

• Hemoglobin Dunn is a novel alpha-globin variant.
• This variant appears to be asymptomatic, with no discernible clinical or hematological abnormalities.
• Further studies may be warranted to fully understand the long-term implications, if any, of Hemoglobin Dunn.